Javier Ribes - Grifols SA CEO of Instituto Grifols SA

GIFLF Stock  USD 8.46  0.00  0.00%   

CEO

Javier Ribes is CEO of Instituto Grifols SA of Grifols SA since 2015.
Tenure 9 years
Phone34 93 571 02 21
Webhttps://www.grifols.com

Grifols SA Management Efficiency

The company has return on total asset (ROA) of 0.0155 % which means that it generated a profit of $0.0155 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0182 %, meaning that it generated $0.0182 on every $100 dollars invested by stockholders. Grifols SA's management efficiency ratios could be used to measure how well Grifols SA manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 6.1 B in total debt with debt to equity ratio (D/E) of 1.14, which is about average as compared to similar companies. Grifols SA has a current ratio of 2.63, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Grifols SA until it has trouble settling it off, either with new capital or with free cash flow. So, Grifols SA's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Grifols SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Grifols to invest in growth at high rates of return. When we think about Grifols SA's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 8 records

CEO Age

Osamu NagayamaRoche Holding Ltd
69
Severin SchwanRoche Holding Ltd
56
Victor DeuGrifols SA ADR
N/A
William AndersonRoche Holding Ltd
57
Nacho AbiaGrifols SA ADR
56
Michael HeuerRoche Holding Ltd
64
PerOlof AttingerRoche Holding Ltd
58
Albert RouraGrifols SA ADR
N/A
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company was founded in 1940 and is headquartered in Barcelona, Spain. Grifols Sa operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 27584 people. Grifols SA [GIFLF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Management Performance

Grifols SA Leadership Team

Elected by the shareholders, the Grifols SA's board of directors comprises two types of representatives: Grifols SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Grifols. The board's role is to monitor Grifols SA's management team and ensure that shareholders' interests are well served. Grifols SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Grifols SA's outside directors are responsible for providing unbiased perspectives on the board's policies.
Antonio Pares, Director of Planning and Control
Peter Allen, Chairman of Hospital OPS Division
Carsten Schroeder, President Of The Diagnostic Division
Albert Roura, CEO of Laboratorios Grifols SA
Jose Garcia, Director General De Laboratorios Grifols
Lafmin Morgan, President Of The Bioscience And Hospital Division
Juan Roura, Vice President of Production, Executive Director
Eva Tubau, Chief Scientific Officer
Anna Lluch, Independent Director
Carlos Fernandez, Deputy Industrial Vice President
Jose Gras, Director, Representative of Thorthol Holdings BV
Maria Llano, Chief Officer
Edgar Jannotta, Independent Director
Vicente Torre, CTO
Mateo Humbert, Director of Human Resources
Montserrat Calvo, Chief Administrative Officer, Controller
Montserrat Llamas, Chief Officer
Ramon Roca, Vice-President of Marketing and Sales and Executive Director
Vctor Deu, CoCEO Director
David Bell, Vice President of Corporate Operations and Development of Grifols Inc and United States Subsidiaries
Victor Deu, Co-CEO, Executive Director
Luis Bobadilla, Independent Director
Inigo Mardones, Director
Thomas Glanzmann, Director
Carina Lazaro, Independent Director
Joel Abelson, President of North America Commercial Division of Grifols Inc
Steven Mayer, Director
Jose Fulla, CEO of Diagnostic Industrial Group
Javier Ribes, CEO of Instituto Grifols SA
Alfredo Guerra, CFO and Corporate VP
Raimon Roura, Non-Member Secretary of the Board
Miguel Montblanch, Chariman of Global Operations Network
Victor Roura, Chairman, CEO and President and Member of Appointments and Remuneration Committee
Brett Ingersoll, Director
Shinji Wada, President of Plasma Centers of Grifols Inc
Tomas Gelabert, Director
Nuria Lapea, Risk Treasury
M Tubau, Co Affairs
Steven JD, Ex Chairman
Marla Salmon, Independent Director
Nuria Barnes, Non-Member Assistant Secretary of the Board
Gregory Rich, President of Grifols Inc and Subsidiaries in the US
Belen Morenes, Independent Director
Nuria Lapena, Director of Shareholder and Investor Relations

Grifols Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Grifols SA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Grifols SA in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Grifols SA's short interest history, or implied volatility extrapolated from Grifols SA options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Grifols SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Complementary Tools for Grifols Pink Sheet analysis

When running Grifols SA's price analysis, check to measure Grifols SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Grifols SA is operating at the current time. Most of Grifols SA's value examination focuses on studying past and present price action to predict the probability of Grifols SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Grifols SA's price. Additionally, you may evaluate how the addition of Grifols SA to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Please note, there is a significant difference between Grifols SA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Grifols SA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Grifols SA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.